Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women

Fig. 1

Disease outcome of TAM-treated ER-positive breast cancer patients. OS and DFS are displayed for all patients (top row), only premenopausal (< 46 years; middle row), and only postmenopausal (≥ 46 years, bottom row) breast cancer patients treated with TAM. The p values were calculated using the log-rank test (Mantel–Cox) and are indicated in each graph

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us